Cargando…

Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis

Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated serum levels of parathyroid hormone (PTH) with persistently normal serum calcium concentrations after excluding secondary causes of hyperparathyroidism. Urolithiasis and/or nephrocalcinosis may occur in hypercalcemic PHPT...

Descripción completa

Detalles Bibliográficos
Autores principales: Victor, Fernanda, Pereira Lemos, Alyne Layane, de Holanda Ribas, Anna Mirella, Bandeira, Leonardo, Pimentel, José Henrique, de Andrade Damázio, Luiz Otávio, Bandeira, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012976/
https://www.ncbi.nlm.nih.gov/pubmed/35437440
http://dx.doi.org/10.1155/2022/4558236
_version_ 1784687906431959040
author Victor, Fernanda
Pereira Lemos, Alyne Layane
de Holanda Ribas, Anna Mirella
Bandeira, Leonardo
Pimentel, José Henrique
de Andrade Damázio, Luiz Otávio
Bandeira, Francisco
author_facet Victor, Fernanda
Pereira Lemos, Alyne Layane
de Holanda Ribas, Anna Mirella
Bandeira, Leonardo
Pimentel, José Henrique
de Andrade Damázio, Luiz Otávio
Bandeira, Francisco
author_sort Victor, Fernanda
collection PubMed
description Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated serum levels of parathyroid hormone (PTH) with persistently normal serum calcium concentrations after excluding secondary causes of hyperparathyroidism. Urolithiasis and/or nephrocalcinosis may occur in hypercalcemic PHPT, but little is known about these complications in NPHPT. Objectives. To identify occult urolithiasis and nephrocalcinosis in asymptomatic patients with NPHPT and evaluate biochemical markers as risk predictors for the development of renal calcification (RC). Methods. Cross-sectional analysis of 34 patients with no history of urolithiasis and/or nephrocalcinosis. The diagnosis of NPHPT was as follows: elevated serum PTH (reference range: 15–65 pg/mL), normal albumin-corrected serum calcium, normal urinary calcium excretion, serum 25(OH)D >30 ng/mL, eGFR (CKD-EPI) > 60 mL/min/1.73 m(2), without intestinal disease, and not on medications such as thiazide diuretics, lithium, bisphosphonates, or denosumab. Patients were categorized according to the presence or absence of RC identified by renal imaging. Their clinical and biochemical characteristics were then compared. Results. The patients had a mean age of 67.97 ± 10.45 years, predominantly postmenopausal women (88.2%); serum PTH, 119.67 ± 64.44 pg/mL; 25(OH)D, 39.00 ± 8.88 ng/dL; 1.25(OH))(2)D, 74.53 ± 26.37 pg/mL; corrected serum calcium, 9.34 ± 0.62 mg/dL; and 24-hour urinary calcium, 134.87 ± 79.68 mg/day. RC was identified in 26.5% of the patients. There was no difference in anthropometric and clinical parameters, renal function, 25(OH)D, and urinary pH in patients with or without RC. Patients with RC had higher PTH values (176.22 vs. 99.32 pg/mL, P = 0.001), 1.25(OH) 2D (96.83 vs. 62.36 pg/mL, P = 0.005), and 24-hour urinary calcium (181.9 vs. 117.94 mg/day, P = 0.037). Conclusion. Occult renal calcifications are common in NPHPT and are associated with increased serum PTH, 1.25(OH))(2)D, and 24 h urinary calcium.
format Online
Article
Text
id pubmed-9012976
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90129762022-04-17 Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis Victor, Fernanda Pereira Lemos, Alyne Layane de Holanda Ribas, Anna Mirella Bandeira, Leonardo Pimentel, José Henrique de Andrade Damázio, Luiz Otávio Bandeira, Francisco Int J Endocrinol Research Article Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated serum levels of parathyroid hormone (PTH) with persistently normal serum calcium concentrations after excluding secondary causes of hyperparathyroidism. Urolithiasis and/or nephrocalcinosis may occur in hypercalcemic PHPT, but little is known about these complications in NPHPT. Objectives. To identify occult urolithiasis and nephrocalcinosis in asymptomatic patients with NPHPT and evaluate biochemical markers as risk predictors for the development of renal calcification (RC). Methods. Cross-sectional analysis of 34 patients with no history of urolithiasis and/or nephrocalcinosis. The diagnosis of NPHPT was as follows: elevated serum PTH (reference range: 15–65 pg/mL), normal albumin-corrected serum calcium, normal urinary calcium excretion, serum 25(OH)D >30 ng/mL, eGFR (CKD-EPI) > 60 mL/min/1.73 m(2), without intestinal disease, and not on medications such as thiazide diuretics, lithium, bisphosphonates, or denosumab. Patients were categorized according to the presence or absence of RC identified by renal imaging. Their clinical and biochemical characteristics were then compared. Results. The patients had a mean age of 67.97 ± 10.45 years, predominantly postmenopausal women (88.2%); serum PTH, 119.67 ± 64.44 pg/mL; 25(OH)D, 39.00 ± 8.88 ng/dL; 1.25(OH))(2)D, 74.53 ± 26.37 pg/mL; corrected serum calcium, 9.34 ± 0.62 mg/dL; and 24-hour urinary calcium, 134.87 ± 79.68 mg/day. RC was identified in 26.5% of the patients. There was no difference in anthropometric and clinical parameters, renal function, 25(OH)D, and urinary pH in patients with or without RC. Patients with RC had higher PTH values (176.22 vs. 99.32 pg/mL, P = 0.001), 1.25(OH) 2D (96.83 vs. 62.36 pg/mL, P = 0.005), and 24-hour urinary calcium (181.9 vs. 117.94 mg/day, P = 0.037). Conclusion. Occult renal calcifications are common in NPHPT and are associated with increased serum PTH, 1.25(OH))(2)D, and 24 h urinary calcium. Hindawi 2022-04-08 /pmc/articles/PMC9012976/ /pubmed/35437440 http://dx.doi.org/10.1155/2022/4558236 Text en Copyright © 2022 Fernanda Victor et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Victor, Fernanda
Pereira Lemos, Alyne Layane
de Holanda Ribas, Anna Mirella
Bandeira, Leonardo
Pimentel, José Henrique
de Andrade Damázio, Luiz Otávio
Bandeira, Francisco
Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title_full Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title_fullStr Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title_full_unstemmed Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title_short Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
title_sort occult renal calcifications in patients with normocalcemic primary hyperparathyroidism and their association with the parathyroid hormone-vitamin d axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012976/
https://www.ncbi.nlm.nih.gov/pubmed/35437440
http://dx.doi.org/10.1155/2022/4558236
work_keys_str_mv AT victorfernanda occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT pereiralemosalynelayane occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT deholandaribasannamirella occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT bandeiraleonardo occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT pimenteljosehenrique occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT deandradedamazioluizotavio occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis
AT bandeirafrancisco occultrenalcalcificationsinpatientswithnormocalcemicprimaryhyperparathyroidismandtheirassociationwiththeparathyroidhormonevitamindaxis